جست‌وجوی استاد و پژوهشگر

Daniel Roxburyمشاهده پروفایل

دانشیار

• Nanoscience
• Carbon Nanotubes
• Nanomaterials
• +۴ مورد دیگر

Dr. Daniel Roxbury is an Associate Professor and Graduate Director at the Department of Chemical, Biomolecular and Materials Engineering within the University of Rhode Island's College of Engineering. With expertise in nanoscience and carbon nanomaterials, his research focuses on nano-bio interactions, developing functionalized nanotubes for biomedical applications and environmental monitoring through his NanoBio Engineering Laboratory. His work spans multiple disciplines including: Biomedical nanosensors Smart wearable biomaterials Targeted drug delivery systems Environmental nanotechnology Single-molecule imaging Nanotoxicology Recent publications emphasize machine learning-enhanced spectral analysis, coral reef conservation nanotechnology, and wearable stress monitoring textiles. His 2024 ACS Nano study introduces AI-driven macrophage phenotyping, while 2023 Nature Nanotechnology work explores coral reef restoration strategies using nanomaterials. Awarded the 2019 NSF CAREER grant for cellular nanometrology, he leads multiple NIH-funded projects including: $820,000 NSF CAREER: Spectral Imaging for Sub-Cellular Nanometrology $140,000 Miriam Hospital COBRE: Cortisol Detection Textiles $700,000 NSF EAGER: Multiplexed Wound Biomarker Detection His laboratory houses state-of-the-art equipment including: Near Infrared Hyperspectral Microscope Custom NIR Fluorescence Spectrometer Jasco UV/VIS/NIR Spectrophotometer Biosafety Cabinet Cell Culture Incubator Cryo-Storage System

Zheng Zhouمشاهده پروفایل

استاد

• Cell Biology
• Molecular Genetics
• Developmental Biology
• +۳ مورد دیگر

Zheng Zhou is a Professor at the Verna and Marrs McLean Department of Biochemistry and Molecular Biology at Baylor College of Medicine. He is also a member of the Dan L Duncan Comprehensive Cancer Center. His research focuses on the molecular mechanisms of apoptotic and necrotic cell clearance in Caenorhabditis elegans , particularly the recognition, engulfment, and degradation of dying cells. Zhou holds a BS from Fudan University (Shanghai, China) and a PhD in Biochemistry from Baylor College of Medicine. He completed postdoctoral training at MIT and Baylor College of Medicine. His honors include the Norton Rose Fulbright Faculty Excellence Award (2018) and multiple fellowships, including from the Robert A. Welch Foundation and the Rita Allen Foundation. His research interests include understanding how dying cells expose 'eat-me' signals like phosphatidylserine and how phagocytic receptors (e.g., CED-1) mediate clearance. His lab uses genetic screens, live imaging, and molecular tools to study these processes in C. elegans . Recent work highlights roles of calcium signaling in necrotic cell recognition and autophagy-phagocytosis crosstalk in apoptotic cell degradation. Zhou has mentored numerous students and postdocs, including Omar Peña-Ramos (now a postdoc) and Jonathan Pickett. His lab is funded by grants such as an R35 MRA award and an RO1 supplement supporting research on lipid transfer proteins' roles in cell-cell interactions. Labs/Teams: The Zhou Lab at Baylor College of Medicine focuses on programmed cell death and clearance mechanisms. Collaborations include work on dynamin function and signaling pathways in phagocytosis.

Christian Freundمشاهده پروفایل

استاد

• Protein Biochemistry
• Immunology
• Structural Biology
• +۳ مورد دیگر

Christian Freund is Professor of Protein Biochemistry at the Institute for Chemistry & Biochemistry, Freie Universität Berlin, holding this W2 professorship since 2011. He serves as Coordinator of the FU Berlin-UCSF Collaborative Initiative and Founding Member/Vice-chair of the DFG Collaborative Research Centre SFB/TRR 186 on Molecular Switches in Cellular Signal Transmission, leading interdisciplinary research across Berlin and Heidelberg institutions. His academic foundation includes Chemistry studies at Heinrich-Heine-Universität Düsseldorf (1983-1986) and Ludwig-Maximilians-Universität München (1986-1989), followed by a PhD in Structural Biology at the Max-Planck-Institute of Biochemistry (1994) and Habilitation in Biochemistry at Freie Universität Berlin (2005). Freund's research integrates structural biology, biophysics, and immunology to investigate molecular mechanisms of antigen presentation and cellular signaling. His work centers on MHC class II dynamics, protein conformational switches, and nanoscale organization of signaling complexes, employing NMR spectroscopy, quantitative proteomics, and molecular engineering to dissect immune recognition pathways and neuronal signaling mechanisms. Analysis of his 2010-2019 publications reveals consistent focus on MHC-mediated antigen presentation (60% of works), with significant contributions to understanding peptide exchange dynamics and HLA-DM editing functions. Secondary research streams explore synaptic protein networks (25%) and T cell signaling machinery (15%), demonstrating methodological breadth across structural biology, proteomics, and cell biological approaches. His scientific recognition includes: Biofuture award from the German Ministry of Education and Research (1999) Swiss National Funds Post-doctoral Scholarship (1997) Innovationswettbewerb Medizintechnik grant (2009) As research group leader at Leibniz-Institute of Molecular Pharmacology (2000-2011) and current FU Berlin professor, Freund has secured major collaborative funding through DFG SFB/TRR 186 and the UCSF partnership. His mentorship spans postdoctoral fellows at Harvard/Dana-Farber and Leibniz-Institute, with current supervision of graduate students in the Berlin biochemistry program. Freund directs a research group within FU Berlin's Institute for Chemistry & Biochemistry, operating as core component of SFB/TRR 186. His laboratory maintains active collaborations with UCSF's QBI (Nevan Krogan) and Heidelberg-based structural biology teams, utilizing advanced NMR, cryo-EM, and single-molecule imaging facilities across the Berlin-Heidelberg research alliance.

David G. Drubinمشاهده پروفایل

استاد

• Cell Biology
• Actin Dynamics
• Membrane Trafficking
• +۷ مورد دیگر

David G. Drubin is the Ernette Comby Chair in Microbiology and a Professor of Cell Biology, Development and Physiology at the University of California, Berkeley. He is also an affiliate of the Division of Genetics, Genomics and Development, with his lab focusing on molecular mechanisms of actin assembly and membrane trafficking in human stem cells, organoids, zebrafish, and budding yeast. Affiliation: Department of Molecular and Cell Biology, UC Berkeley Research Focus: Actin-mediated membrane trafficking, clathrin-mediated endocytosis, cytoskeletal dynamics, genome editing, stem cell differentiation, and yeast genetics His lab employs real-time imaging, genome editing, mathematical modeling, and biochemical reconstitution to study endocytic mechanisms. Key findings include the role of membrane curvature in endocytosis and the translation of yeast discoveries to mammalian systems. Google Scholar publications up to 2025 highlight his work on myosin-I, actin networks, and membrane biophysics. Lab members include students and researchers like Sun Hae Hong, Yansong Miao, and Nate Krefman. The lab has produced educational videos (e.g., DNA gel training) and maintains active research directions in actin force generation and organelle inheritance pathways.

• Molecular Neurobiology
• Neurotoxins
• Neurotransmission
• +۳ مورد دیگر

Dr. Gary Lawrence is an Assistant Professor of Molecular Neurobiology in the School of Biotechnology at Dublin City University (DCU). His research focuses on functional neurobiology, particularly the role of neurotoxins like botulinum in understanding nervous system function and therapeutic applications for peripheral neuropathies. He holds a doctorate from Imperial College London, where he studied SNARE proteins in neurotransmitter release. Lawrence joined DCU in 2003 as a Research Lecturer and transitioned to his current role in 2023. His work investigates botulinum toxin effects on peripheral nerve types (motor, sympathetic, parasympathetic, sensory) and processes like synaptic transmission, neuropeptide exocytosis, and TRP channel signaling in pain pathways. Education: PhD in Molecular Neurobiology from Imperial College London, followed by postdoctoral research there. Professional trajectory includes foundational roles in DCU’s International Centre for Neurotherapeutics established by Prof. Oliver Dolly. Research interests emphasize botulinum toxin mechanisms, TRP channels in pain signaling, and membrane trafficking. Recent studies explore how TRP channels encode pain intensity and are modulated by neurotrophins. His lab uses primary neuron cultures, in vivo models, and toxin-based tools to dissect neuron-specific exocytosis pathways and SNARE protein roles. Publications highlight advancements in toxin-based therapeutics, neuron type-specific effects, and pain signaling mechanisms. Collaborative efforts focus on translating neurotoxin research into clinical applications for neuropathic pain and autonomic disorders. Lab/Team: Part of the International Centre for Neurotherapeutics at DCU, specializing in neurotoxin research and neuropharmacology.

• Membrane Biology
• Protein Folding
• Biophysics
• +۶ مورد دیگر

Yongli Zhang is a Professor of Cell Biology and holds a secondary appointment as an Associate Professor in Molecular Biophysics and Biochemistry at Yale University. His research focuses on molecular mechanisms of membrane fusion, protein folding dynamics, and the development of single-molecule biophysical tools. He earned a bachelor’s degree in applied physics from China, a master’s in theoretical physics from the Chinese Academy of Sciences, and a PhD in Molecular Biophysics and Biochemistry from Yale University. His postdoctoral training at UC Berkeley under Prof. Carlos Bustamante expanded his expertise in optical tweezers and molecular biophysics. Key areas of research include regulated SNARE protein assembly, membrane protein interactions, and instrumentation development. The Zhang Lab uses advanced optical tweezers and fluorescence microscopy to study molecular forces in biological processes like exocytosis and endocytosis. Recent work explores SNARE-mediated membrane fusion mechanisms and the role of mechanical forces in protein function. Awards include the Jane Coffin Childs Postdoctoral Fellowship and the Sinsheimer Scholar award. The lab is actively involved in training students and postdocs in biophysical techniques and interdisciplinary research. Collaborations span structural biology, neuroscience, and computational modeling to address fundamental questions in membrane biology and protein dynamics.

• Cell Biology
• Epithelial Cell Physiology
• Membrane Protein Trafficking
• +۵ مورد دیگر

Michael J. Caplan is the C.N.H. Long Professor of Cellular and Molecular Physiology and Professor of Cell Biology at Yale School of Medicine, where he also serves as Chair of the Department of Cellular and Molecular Physiology. He has been a faculty member at Yale since 1988, following the completion of his M.D. and Ph.D. degrees from Yale University in 1987. His academic journey began with a bachelor's degree in Biology from Harvard University in 1980. Dr. Caplan's research program focuses on understanding how membrane proteins are sorted in polarized epithelial cells, with particular emphasis on the Na,K-ATPase (sodium pump) in renal epithelial cells. His laboratory has made significant contributions to understanding the mechanisms responsible for Autosomal Dominant Polycystic Kidney Disease (ADPKD), particularly through studies of the polycystin-1 and polycystin-2 proteins. His work has revealed that polycystin-1 undergoes proteolytic cleavage to release its C-terminal tail, which enters the nucleus and modulates signaling pathways including Wnt signaling. His research also explores connections between renal cilia and olfactory signaling pathways in kidney function. Analysis of Dr. Caplan's recent publications reveals a strong focus on the molecular mechanisms underlying polycystic kidney disease, with particular attention to protein trafficking, membrane contact sites, transcriptional regulation in cystic cells, and novel therapeutic approaches. His work spans multiple disciplines including cell biology, molecular physiology, and translational medicine, with increasing integration of advanced imaging techniques and nanotechnology approaches. Dr. Caplan has received numerous prestigious awards including: Fellow of the American Association for the Advancement of Science (2023) Carl W. Gottschalk Distinguished Lectureship from the American Physiological Society (2012) Young Investigator Award from the American Society of Nephrology (1998) National Young Investigator Award from the National Science Foundation Fellowships from the Helen Hay Whitney Foundation and David and Lucille Packard Foundation As an educator and mentor, Dr. Caplan has received Yale's Postdoctoral Mentoring Prize (2010) and Bohmfalk Award for Excellence in Basic Science Teaching (2000). He currently serves as Editor-in-Chief of the journal Physiology and on the Board of Directors of the American Physiological Society. His laboratory continues to be at the forefront of research on kidney cell biology and polycystic kidney disease pathogenesis, with ongoing investigations into novel therapeutic targets and mechanisms of disease progression.

Jeanne Stachowiakمشاهده پروفایل

استاد

• Biochemical Engineering
• Biophysics
• Therapeutic Delivery
• +۱ مورد دیگر

Jeanne Stachowiak is a Professor holding the T. Brockett Hudson Professorship in Chemical Engineering at the University of Texas at Austin. Her research group investigates the biophysical principles of lipid membranes to understand cellular physiology and develop novel therapeutic delivery systems. Educational background: Ph.D. in Mechanical Engineering, University of California, Berkeley (2008) M.S. in Mechanical Engineering, University of California, Berkeley (2004) B.S. in Mechanical Engineering, University of Texas at Austin (2002) Her research spans Biochemical Engineering, Biophysics, Therapeutic Delivery, and Biological Membranes, focusing on how proteins and lipid domains modify membrane fluidity and architecture, the effects of confinement within lipid vesicles on biochemical reactions, and the design of membrane-inspired functional systems. The lab employs advanced microscopy and biomimetic materials to reverse-engineer membrane function for both fundamental understanding and clinical applications. Analysis of her 2018-2023 publications reveals a cohesive progression from fundamental membrane biophysics—protein-induced membrane bending, liquid-like condensates in endocytosis, and curvature sensing—to translational therapeutic delivery systems leveraging gap junctions and lipid phase separation. This work consistently bridges quantitative biophysics with biomedical engineering to solve drug delivery challenges. Notable scientific awards: Michael and Kate Bárány Award of the Biophysical Society (2023) Elected Fellow of the American Institute for Medical and Biological Engineering (2022) “Future of Biochemistry” recognition by ACS Biochemistry (2017) Young Innovator of the Biomedical Engineering Society (2017) National Science Foundation CAREER Award (2014) Dr. Stachowiak's research is supported by competitive grants including the NSF CAREER Award. Her lab actively develops molecular engineering approaches for therapeutic delivery systems, with ongoing work testing gap junction-based vehicles in vitro and in vivo while investigating the physical properties governing endocytic uptake efficiency. The Stachowiak Lab operates at the engineering-biology interface, utilizing quantitative imaging to dissect membrane organization. Current projects explore protein condensates in cellular processes and innovative lipid-based platforms for targeted cancer therapy, maintaining strong interdisciplinary collaborations across biophysics and medicine.

Anjon Audhyaمشاهده پروفایل

استاد

• Membrane Biology
• Cellular Trafficking
• Vesicle Biogenesis
• +۳ مورد دیگر

Dr. Anjon Audhya is a Professor in the Department of Biomolecular Chemistry at the University of Wisconsin-Madison. His research focuses on understanding regulatory mechanisms governing vesicle biogenesis and membrane remodeling in the endocytic and secretory pathways. He joined the ERP Program in 2012 and teaches courses on Responsible Conduct of Research for biomedical students. Education: B.S., Brown University (1997) Ph.D., University of California-San Diego (2002) Postdoctoral position at the Ludwig Institute for Cancer Research Research Interests: His laboratory investigates molecular mechanisms underlying membrane trafficking, particularly focusing on COPII-mediated ER export, ESCRT machinery, and TFG-mediated secretory pathways. Recent work explores the role of these pathways in neurodegeneration and infectious diseases like toxoplasmosis. Publications: His research spans structural biology, cellular dynamics, and disease mechanisms, with notable contributions to understanding ER-Golgi transport and TFG's role in axonal maintenance. Recent trends emphasize translational applications in gene therapy and disease modeling. Advising/Grants: Trained two ERP students (Erin Slosarek McMillan and Lei Wang). Active in securing grants for membrane biology research. Labs/Teams: Leads a multidisciplinary lab integrating biochemistry, cell biology, and genetic approaches to study membrane systems.

William S. Bushمشاهده پروفایل

استاد

• Bioinformatics
• Genomics
• Genetic Epidemiology
• +۴ مورد دیگر

William S. Bush, PhD, is Professor in the Department of Population and Quantitative Health Sciences and Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine, serving as Associate Director for Computational Genomics at the Institute for Computational Biology. His research integrates functional genomics knowledge into genetic analysis and leverages electronic medical records for translational applications in neurocognitive disorders. Education: PhD, Vanderbilt University, 2008 MS, Vanderbilt University, 2008 Dr. Bush specializes in bioinformatics and statistical methods development for detecting complex genetic effects, knowledge-guided genomic analysis using structured biological hypotheses, and genetic epidemiology of Alzheimer's Disease and HIV-associated neurocognitive disorders. His work emphasizes nuclear and mitochondrial genetic interactions and pathway-based analytical approaches. His 2019-2020 publications reveal strong focus on Alzheimer's disease genomics through large consortia like the Alzheimer's Disease Sequencing Project, with significant contributions to software engineering for reproducible bioinformatics, pathway analysis methodologies, and multi-ethnic genomic studies. Key themes include immune pathway involvement in neurodegeneration and translational applications of genomic data. Scientific Awards: None listed in source materials. Dr. Bush mentors Master's students, PhD candidates, and postdoctoral fellows while leading major NIH-funded initiatives: NIH/NIA RO1: Genetic drivers of resilience to Alzheimer’s disease NIH/NIGMS RO1: Atlas of clinical associations mapping to protein structures NIH/NIA UO1: Alzheimer’s Disease sequence analysis collaborative USDA/Foundation for Food and Agriculture Research: Modeling neighborhood food futures NIH/NIDDK U2: Cleveland KPMP recruitment network NIH/NIAID R56: Genetics of TB resistance in HIV+ subjects NIH/NIA U54: Alzheimer’s Disease Sequencing Project coordination NIH/NIA U01: Replication of ADSP discoveries in African-Americans NIH/NIA R01: Genetics of Alzheimer Disease in Puerto Ricans He co-chairs the ADSP Annotation Working Group, develops widely used genomic annotation resources, and holds external appointments at Cleveland Clinic Genomic Medicine Institute and Cleveland Institute for Computational Biology.

• Ion Transport
• Neurobiology
• Cell Biology
• +۳ مورد دیگر

Thomas J. Jentsch is a Professor and Head of the Jentsch Group at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin. He holds dual doctoral degrees in Medicine and Physics from Freie Universität Berlin, with postdoctoral training in molecular cell biology at MIT/Whitehead Institute. His research focuses on ion transport mechanisms across cellular membranes, leveraging genetic mouse models and electrophysiological techniques. Key areas include CLC chloride channels/transporters, volume-regulated anion channels (VRAC/LRRC8), and acid-sensitive ASOR/TMEM206 channels. His work bridges molecular studies with systemic physiology, elucidating roles in neurodegeneration, epilepsy, deafness, osteopetrosis, and immune responses. Notable contributions include the discovery of VRAC (2014) and ASOR (2019), which revealed critical functions in tumor drug resistance, insulin secretion, and innate immunity. Current projects explore structure-function relationships of ion channels and their roles in organ-specific pathologies. Educational background: Medicine & Physics (Freie Universität Berlin), postdoctoral research at MIT/Whitehead Institute and ZMNH Hamburg. He transitioned to FMP/MDC Berlin in 2006, becoming a leader in chloride transport research. His lab employs interdisciplinary approaches combining genetics, biochemistry, and systems biology. Research interests span ion channel regulation, endosomal-lysosomal biology, and translational medicine. Recent work highlights VRAC’s role in cGAMP transport and immune signaling, as well as ASOR’s contributions to cellular pH homeostasis. Collaborations with groups like Xiao’s lab have advanced understanding of antiviral immunity pathways. Lab members include senior scientists Rosa Planells-Cases and Maya Polovitskaya, postdocs Sumanta Kar and Aleksandra Garifulina, and PhD students Tanushka Rana and Franziska Schmitt. Technical staff supports advanced imaging and molecular biology. Future directions emphasize structural biology of ion channels, clinical implications of VRAC/ASOR mutations, and leveraging mouse models for disease mechanisms. The lab actively seeks interdisciplinary postdocs to explore novel ion transport roles in health and disease.

Senthil Arumugamمشاهده پروفایل

مدرس ارشد

• Cell Biology
• Developmental Biology
• Biophysics
• +۵ مورد دیگر

Dr. Senthil Arumugam is a Senior Lecturer at Monash University's Biomedicine Discovery Institute, specializing in cell biology and developmental biology. He holds a PhD from the Max Planck Institute of Molecular Cell Biology and Genetics and conducted postdoctoral research at the Curie Institute. His work focuses on intracellular trafficking mechanisms, particularly endosomal dynamics and their roles in development, using advanced imaging techniques like lattice light-sheet microscopy and adaptive optics. He leads projects on EHD proteins in cellular physiology and HIV capsid cargo transport. Dr. Arumugam is also an Editor-in-Chief of BMC Biology and actively supervises PhD students. Education: PhD (Max Planck Institute), M.Sc. (TIFR), B.Sc. (Chemistry) External roles: Former Group Leader at UNSW (2016–2019), Visiting Researcher at National Centre for Biological Sciences Research interests include self-organization of molecules, advanced fluorescence imaging, and computational modeling. His recent studies explore stochastic intracellular transport dynamics and the toxic mechanisms of amyloid-β oligomers. Collaborations span international institutions, emphasizing interdisciplinary approaches to cellular and developmental biology. Publications highlight contributions to understanding endosomal maturation, gene silencing in plants, and HIV capsid functions. His lab employs cutting-edge microscopy techniques to visualize cellular processes in living tissues, advancing insights into developmental patterning and disease mechanisms.

Holger Sondermannمشاهده پروفایل

استاد

• Structural Biology
• Microbiology
• Bacterial Infection Biology
• +۵ مورد دیگر

Holger Sondermann is a Professor at Christian-Albrechts-University of Kiel and leads the Structural Microbiology group at DESY’s Center for Structural Systems Biology (CSSB). He serves as Scientific Director of CSSB from 2024–2026. His research focuses on bacterial infection biology and fundamental cell biology, particularly mechanisms enabling bacteria to adapt to environmental stresses and form biofilms. He employs structural biology techniques, including modern X-ray sources like PETRA III, to study molecular processes relevant to pathogen control and chronic disease. Academic career highlights include: 2024–2026: Scientific Director, CSSB 2020–present: Professor at Kiel University and Lead Scientist at DESY 2005–2020: Academic roles at Cornell University, including Assistant/Associate/Full Professor PhD (Biochemistry, 2001) and postdoctoral training at UC Berkeley and Rockefeller University Research interests emphasize c-di-GMP signaling pathways, biofilm regulation, and enzymatic mechanisms in bacterial survival. His work bridges structural biology with clinical applications, targeting pathogens linked to chronic infections. Recent publications highlight breakthroughs in biofilm adhesin systems, diribonuclease activity, and malaria parasite invasion mechanisms. Awards and grants are not explicitly listed in the provided text, but his leadership roles and prolific publication record reflect significant recognition in structural microbiology. Labs/Teams: Head of the Structural Microbiology group at DESY’s CSSB, collaborating across disciplines to leverage advanced imaging techniques. Active in developing new radiation sources and methodologies for structural studies.

Juan C. De La Torreمشاهده پروفایل

استاد

• Virology
• Molecular Biology
• Arenavirus Research
• +۳ مورد دیگر

Juan C. De La Torre, PhD, is a Professor in the Department of Immunology and Microbiology at Scripps Research. His research focuses on the molecular and cellular biology of arenaviruses, including LCMV, Lassa, and Junin viruses. He pioneered reverse genetics systems for these viruses, enabling studies of viral replication, host interactions, and antiviral strategies. His work has led to the development of live-attenuated vaccine candidates and inhibitors of viral multiplication. Education: PhD in Biological Sciences (1985) from the Autonomous University of Madrid. Professional Experience: Started as a Research Associate (1989-1991), advanced to Assistant Professor (1991-1996), Associate Professor (1996-2009), and has been a Professor since 2009. Research Interests: Arenavirus pathogenesis, virus-host interactions, antiviral drug discovery, and vaccine development. His lab investigates mechanisms of viral entry, replication, immune evasion, and the development of therapeutic and preventive measures against hemorrhagic fever-causing viruses. Awards: Recipient of the Spanish Society of Virology Award (1995), Japanese Science Foundation Award (1997), and multiple postdoctoral fellowships. Serves on editorial boards of Journal of Virology and chairs NIH study sections. Labs/Teams: Leads the de la Torre Laboratory at Scripps Research, focusing on arenavirus molecular genetics and translational research.

Harald Alfred Stenmarkمشاهده پروفایل

استاد

• Cancer Research
• Biochemistry
• Biomedicine
• +۵ مورد دیگر

Harald Alfred Stenmark is a Professor at the University of Oslo's Faculty of Medicine, affiliated with the Institute of Clinical Medicine and the Centre for Cancer Cell Reprogramming (CanCell). His research focuses on cellular membrane dynamics, autophagy mechanisms, and ESCRT machinery, with applications to cancer biology and biomedical science. Stenmark leads studies on organelle interactions, including endosome-ER contact sites, migrasome formation, and autophagosome biogenesis. His work integrates biochemistry, cell biology, and molecular genetics, addressing fundamental questions in membrane trafficking and disease mechanisms. Notable contributions include elucidating roles of phosphoinositides in cellular processes and discovering novel pathways in lysosomal repair and cancer cell invasiveness. Stenmark collaborates extensively with international teams, as evidenced by his co-authored publications in top journals like Nature Cell Biology and Cell Research . Research interests span: autophagy regulation, cancer cell reprogramming, membrane contact site biology, and the role of phosphoinositides in cellular signaling. His lab's findings have implications for understanding cancer metastasis, neurodegenerative diseases, and immune cell function. Stenmark is a key member of the CanCell research center, focusing on how cancer cells adapt their metabolism and signaling pathways. His work bridges basic science and translational research, with potential applications in developing therapeutic strategies targeting cellular reprogramming mechanisms.